- Home
- ILMN vs FUTU Comparison
ILMN vs FUTU Comparison
Compare ILMN & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- FUTU
- Stock Information
- Founded
- ILMN 1998
- FUTU 2011
- Country
- ILMN United States
- FUTU Hong Kong
- Employees
- ILMN N/A
- FUTU N/A
- Industry
- ILMN Medical Specialities
- FUTU Investment Bankers/Brokers/Service
- Sector
- ILMN Health Care
- FUTU Finance
- Exchange
- ILMN Nasdaq
- FUTU Nasdaq
- Market Cap
- ILMN 16.9B
- FUTU 19.7B
- IPO Year
- ILMN 2000
- FUTU 2019
- Fundamental
- Price
- ILMN $94.78
- FUTU $159.50
- Analyst Decision
- ILMN Buy
- FUTU Strong Buy
- Analyst Count
- ILMN 17
- FUTU 5
- Target Price
- ILMN $127.00
- FUTU $160.38
- AVG Volume (30 Days)
- ILMN 2.3M
- FUTU 2.4M
- Earning Date
- ILMN 07-31-2025
- FUTU 08-19-2025
- Dividend Yield
- ILMN N/A
- FUTU 1.22%
- EPS Growth
- ILMN N/A
- FUTU 58.31
- EPS
- ILMN 7.91
- FUTU 6.00
- Revenue
- ILMN $4,284,000,000.00
- FUTU $1,788,948,850.00
- Revenue This Year
- ILMN N/A
- FUTU $48.32
- Revenue Next Year
- ILMN $2.78
- FUTU $10.00
- P/E Ratio
- ILMN $11.99
- FUTU $26.80
- Revenue Growth
- ILMN N/A
- FUTU 54.51
- 52 Week Low
- ILMN $68.70
- FUTU $56.22
- 52 Week High
- ILMN $156.66
- FUTU $174.36
- Technical
- Relative Strength Index (RSI)
- ILMN 43.93
- FUTU 60.00
- Support Level
- ILMN $93.32
- FUTU $155.28
- Resistance Level
- ILMN $99.54
- FUTU $161.36
- Average True Range (ATR)
- ILMN 3.76
- FUTU 5.78
- MACD
- ILMN -1.57
- FUTU -1.20
- Stochastic Oscillator
- ILMN 13.77
- FUTU 55.25
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.